Details for Patent: 10,933,120
✉ Email this page to a colleague
Which drugs does patent 10,933,120 protect, and when does it expire?
Patent 10,933,120 protects RYBELSUS and is included in one NDA.
This patent has thirty-nine patent family members in twenty-four countries.
Summary for Patent: 10,933,120
| Title: | Compositions of GLP-1 peptides and preparation thereof |
| Abstract: | The invention relates to pharmaceutical compositions comprising a first type of granules and a second type of granules, wherein said first type of granules comprises a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and no GLP-1 peptide, and wherein said second type of granules comprises a GLP-1 peptide and no salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, as well as the intermediate granules, processes for the preparation of the granules and compositions, and use thereof in medicine. |
| Inventor(s): | Vilhelmsen; Thomas (Karslunde, DK), Eliasen; Helle (Koege, DK), Hansen; Tue (Copenhagen S, DK) |
| Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
| Application Number: | 14/386,589 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 10,933,120
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | RYBELSUS | semaglutide | TABLET;ORAL | 213051-001 | Sep 20, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Novo | RYBELSUS | semaglutide | TABLET;ORAL | 213051-002 | Sep 20, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Novo | RYBELSUS | semaglutide | TABLET;ORAL | 213051-003 | Sep 20, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,933,120
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 12160743 | Mar 22, 2012 | |
| 13153459 | Jan 31, 2013 | |
| PCT Information | |||
| PCT Filed | March 15, 2013 | PCT Application Number: | PCT/EP2013/055362 |
| PCT Publication Date: | September 26, 2013 | PCT Publication Number: | WO2013/139694 |
International Family Members for US Patent 10,933,120
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013234496 | ⤷ Try a Trial | |||
| Australia | 2017251814 | ⤷ Try a Trial | |||
| Brazil | 112014023374 | ⤷ Try a Trial | |||
| Canada | 2868188 | ⤷ Try a Trial | |||
| China | 104203266 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
